HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting.

Abstract
Targeted therapy for the treatment of cancers using nanoparticles (NPs) decorated with transferrin (Tf) has been relatively successful, as several such nanocarriers are currently undergoing clinical trials. However, since native Tf has a low probability of delivering its payload due to its short residence time in the cell, or low cellular association, there is room to significantly improve the potency of current systems. We pioneered the redesign of this targeting ligand by altering the ligand-metal interaction, as suggested by our mathematical model, and here we present the first study to investigate the enhanced therapeutic efficacy of NPs conjugated to our engineered oxalate Tf. Our mathematical model was first used to predict that NPs conjugated to oxalate Tf will exhibit a higher degree of cellular association compared to native Tf-conjugated NPs. Our in vitro trafficking experiments validated the model prediction, and subsequent in vitro and in vivo efficacy studies demonstrated that this increase in cellular association further translates into an enhanced ability to deliver chemotherapeutics. Our findings signify the importance of the cellular trafficking properties of targeting ligands, as they may significantly influence therapeutic potency when such ligands are conjugated to NPs. Given the early success of a number of native Tf-conjugated NPs in clinical trials, there is potential for using Tf-variant based therapeutics in systemic drug delivery applications for cancer treatment.
AuthorsRicky Y T Chiu, Takuma Tsuji, Stephanie J Wang, Juntian Wang, Christina T Liu, Daniel T Kamei
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 180 Pg. 33-41 (Apr 28 2014) ISSN: 1873-4995 [Electronic] Netherlands
PMID24524898 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Drug Carriers
  • Transferrin
  • Oxalic Acid
  • Iron
Topics
  • Animals
  • Cell Line, Tumor
  • Drug Carriers (chemistry, metabolism)
  • Drug Delivery Systems (methods)
  • Humans
  • Iron (metabolism)
  • Male
  • Mice
  • Models, Biological
  • Nanoparticles (chemistry, metabolism)
  • Neoplasms (drug therapy, metabolism)
  • Oxalic Acid (chemistry, metabolism)
  • Transferrin (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: